| Literature DB >> 33239406 |
Keir Ej Philip1,2, Adam Lewis3, Edmund Jeffery2, Sara Buttery4,2, Phoene Cave4, Daniele Cristiano2, Adam Lound5, Karen Taylor2, William D-C Man4,2, Daisy Fancourt6, Michael I Polkey4,2, Nicholas S Hopkinson4,2.
Abstract
INTRODUCTION: Singing for lung health (SLH) is a popular arts-in-health activity for people with long-term respiratory conditions. Participants report biopsychosocial benefits, however, research on impact is limited. The 'SLH: Improving Experiences of Lung Disease trial', a randomised controlled, single (assessor) blind, trial of 12 weeks SLH versus usual care for people with chronic obstructive pulmonary disease (COPD) (n=120) was setup to help to address this. The first group (n=18, nine singing and nine controls) started face-to-face (five sessions) before changing to online delivery (seven sessions) due to COVID-19-related physical distancing measures. As such, the experience of this group is here reported as a pilot study to inform further research in this area.Entities:
Keywords: complementary medicine; exercise; infection control; viral infection
Mesh:
Year: 2020 PMID: 33239406 PMCID: PMC7689537 DOI: 10.1136/bmjresp-2020-000737
Source DB: PubMed Journal: BMJ Open Respir Res ISSN: 2052-4439
Figure 1Moving singing for lung health online: experience from a randomised controlled trial: CONSORT diagram. CONSORT, Consolidated Standards of Reporting Trials.
Baseline characteristics
| Singing for lung health | Usual care (n=9) | P value | |
| Age | 72.1 (9.65) | 69.89 (9.36) | 0.63 |
| Female | 3 (33%) | 6 (66%) | 0.18 |
| BMI | 23.30 (7.20) | 25.52 (6.41) | 0.50 |
| FEV1 % predicted | 56.39 (35.57) | 35.01 (17.84) | 0.13 |
| Oxygen therapy | 1 (11%) | 2 (22%) | 0.60 |
| Pack years smoked | 36.23 (19.95) | 41.89 (31.26) | 0.66 |
| Falls in last year | 1 (11%) | 1 (11%) | 1.00 |
| Baseline 6MWD | 418 (136.23) | 366 (82.30) | 0.34 |
| SPPB total | 9.56 (2.19) | 9.11 (2.32) | 0.68 |
| Prestudy expectation of SLH health impact | 4.56 (1.33) | 4.56 (2.24) | 1.00 |
| SF-36 Physical Component Score | 39.11 (8.39) | 34.91 (8.26) | 0.30 |
| SF-36 Mental Component Score | 45.76 (4.60) | 41.52 (35.16) | 0.20 |
| SF-36 Physical function | 43.89 (26.43) | 36.67 (27.95) | 0.58 |
| SF-36 Role limitation, physical | 50.00 (41.46) | 25.00 (39.53) | 0.21 |
| SF-36 Role limitation, emotional | 85.19 (24.22) | 62.97 (35.14) | 0.14 |
| SF-36 energy | 40.56 (17.40) | 42.23 (18.05) | 0.84 |
| SF-36 emotional well being | 74.67 (11.66) | 66.23 (14.44) | 0.19 |
| SF-36 social functioning | 79.17 (20.73) | 61.11 (34.60) | 0.20 |
| SF-36 pain | 65.56 (21.71) | 61.39 (29.77) | 0.74 |
| SF36 general health | 32.22 (13.94) | 31.11 (14.95) | 0.87 |
| SF-36 health change | 47.22 (19.54) | 52.78 (23.20) | 0.59 |
| Depression (PHQ-9) | 5.00 median (IQR 3.00–8.00) | 6.00 median (IQR 5.00–14.00) | 0.28 (WRS) |
| Anxiety (GAD-7) | 2.00 median (IQR 1.00–2.00) | 5.00 median (IQR 0.00–11.00) | 0.23 (WRS) |
| ABC scale score | 78.75 median (IQR 50.63–90.63) | 76.25 median (IQR 64.38–91.25) | 0.72 (WRS) |
| Dyspnoea 12 | 11.00 median (IQR 7.00–15.00) | 13.00 median (IQR 8.00–20.00) | 0.27 (WRS) |
| MRC dyspnoea score | 2.89 (0.93) | 3.00 (1.32) | 0.84 |
| CAT score | 18.11 (7.10) | 21.00 (7.57) | 0.42 |
| PROactive difficulty* | 68.56 (13.28) | 63.11 (14.60) | 0.42 |
| PROactive amount† | 53.67 (14.14) | 46.67 (18.21) | 0.38 |
| PROactive total‡ | 61.11 (12.06) | 54.89 (13.86) | 0.32 |
| Daily step count | 2717 median (IQR 1870–4871) | 2566 median (IQR 1213–3119) | 0.40 (WRS) |
Data shown are mean (SD), or if appropriate, median (IQR)/number (%) as indicated. P values are for ttests for between groups differences, or Wilcoxon rank-sum (WRS) as marked, if appropriate.
*Scale of 0 (high level difficulty) to 100 (low level of difficulty).
†Scale of 0 (low amount) to 100 high amount.
‡Total score calculated as mean of PROactive difficulty and PROactive amount (0–100).
ABC, Activity specific Balance Confidence; BMI, body mass index; CAT, COPD Assessment Test; FEV1, forced expiratory volume in 1 s; GAD-7, Generalised Anxiety Disorder-7; MRC, Medical Research Council; 6MWD, 6 min walk distance; PHQ-9, Patient Health Questionnaire-9; PROactive, Patient Reported Outcome measure forphysical activity in COPD; SF-36, Short Form 36 Health Survey; SPPB, short physical performance battery; WRS, Wilcoxon rank-sum.
Considerations for online versus face-to-face delivery of singing for lung health (SLH) based on participant and facilitator experience
| Face to face | Online | |
| Access: Physical | More challenging | Private physical space still required for participant. |
| Access: Online | Limited or no requirement | Computer/device and internet access required. |
| Digital literacy | Not required | Required |
| Infection/health risks | Potential risk of cross infection from participants or infection during transport to/from session. | Not supervised in person |
| Social experience | Very effective and important to participants. | Good (perhaps less than face to face) |
| Personal experience | Presence of peers can be both supportive and slightly intimidating depending on individual and group dynamic. | The required technological skills can induce mild anxiety if participant not confident/experienced. |
| Physical engagement | Important aspect of session | More challenging than face to face |
| Facilitator experience | Easier to gauge participant emotions and group dynamic. | More challenging to assess if appropriate techniques are being used by participants. |
Practical issues transferring face to face to online based on participant and facilitators experience
| Informing participants | People are generally understanding of current requirement for physically distanced sessions. |
| Joining online | Participants may need support with digital access. |
| Physical space | Clean, tidy and free from trip hazards. |
| Sound | Speakers advisable for better volume and sound quality |
| Feedback | Integration of formal feedback vital to facilitate responsive and participant appropriate sessions. |
| Maintaining/building relationships | Introductions. |
| Session content | Cannon and multi-harmonies (live)—difficult. |
| Keep up to date | The evidence base is in this area is evolving, so ongoing review of relevant research and guidelines is important, including related activities such as pulmonary rehabilitation. |
| Safety | Ensure contact details are correct. |
| Ethical Issues | Participants should consent to any use of their personal data. |
SLH, singing for lung health.
Comparison of change in outcome measures between study arms
| Singing for lung health (SLH) (n=9) | Usual care (UC) (n=9) | Treatment effect | P value | |
| SF-36 Physical Component Score | −1.66 | −0.389 | −1.27 (−7.13 to +4.60) | 0.67 |
| SF-36 Mental Component Score | −0.367 | −4.30 | +3.93 (−3.85 to +11.72) | 0.15 |
| SF-36 Physical function | −1.11 | 2.77 | −3.89 (−14.02 to +6.24) | 0.79 |
| SF-36 Role limitation, physical | −16.67 | −2.78 | −13.89 (−42.44 to +14.66) | 0.84 |
| SF-36 Role limitation, emotional | −7.41 | −33.33 | +25.92 (−14.51 to +66.35) | 0.10 |
| SF-36 energy | 6.11 | −1.11 | +7.22 (−9.59 to +24.03) | 0.19 |
| SF-36 emotional well-being | 2.22 | −6.22 | +8.44 (−7.62 to +24.51) | 0.14 |
| SF-36 social functioning | −6.95 | −15.28 | +8.33 (−18.85 to +35.52) | 0.26 |
| SF-36 pain | 0.28 | 5.78 | −5.50 (+29.57 to +18.57) | 0.68 |
| SF-36 general health | 0 | 1.67 | −1.67 (−12.98 to +9.65) | 0.62 |
| SF-36 health change over last year | 5.56 | −13.89 | +19.44 (−0.09 to +38.97) | |
| Depression (PHQ-9) | −1.44 | +3.33 | −4.78 (−10.53 to +0.98) | |
| Anxiety (Median (IQR)) | 0.00 (0.00 to 1.00) | 2.00 (0.00 to 3.00) | 2.00 | 0.24 |
| ABC scale score | 6.03 | −11.18 | +17.21 (−2.07 to +36.49) | |
| Dyspnoea 12 | −0.445 | 0.445 | −0.89 (−7.69 to +5.91) | 0.39 |
| MRC dyspnoea score | 0.222 | 0.111 | +0.11 (−0.61 to +0.84) | 0.63 |
| CAT score | −1.44 | 2.22 | −3.67 (−9.42 to +2.08) | 0.10 |
| PROactive Difficulty* | 0.889 | −1.12 | +2.00 (−9.78 to +13.79) | 0.362 |
| PROactive amount† | −20.22 | −6.89 | −13.33 (−30.07 to +3.41) | 0.95 |
| PROactive total‡ | −9.67 | −4.00 | −5.67 (−13.68 to +2.35) | 0.92 |
| Daily step count (median IQR)) | −531 (–823–-65) | −372 (−1123–150) | −159 | 0.76 |
P values are one-tailed independent sample t-tests of mean change preintervention–postintervention, for superiority of SLH over UC, or Wilcoxon rank-sum test if non-parametric test required, with median (IQR) shown.
*Change in the scale of 0 (high level difficulty) to 100 (low level of difficulty);.
†Change in the scale of 0 (low amount) to 100 high amount.
‡Change in the scale of the total score calculated as mean of PROactive difficulty and PROactive amount (0–100). MCID for the PHQ-9 is 5 points39; MCID for ABC score is 14.2 points.40
ABC, Activity specific Balance Confidence; CAT, COPD Assessment Test; MRC, Medical Research Council; PHQ-9, Patient Health Questionnaire-9; SF-36, Short Form 36 Health Survey.